Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.
What happened
FDA inspected Greco Gas's drug manufacturing facility in Tarentum, PA, from March 27 to April 5, 2024. Investigators found the firm did not test incoming components or finished batches of Oxygen, USP and Nitrogen, NF, had equipment uncalibrated since 2020, and did not investigate container-closure leaks. Employees also recorded testing and calibration results they did not actually perform.
What FDA found
The firm did not run an identity test on each lot of incoming components and relied on supplier certificates of analysis (COAs, the supplier's own test report) without checking that those supplier tests were reliable.
21 CFR 211.84(d)(1) and 211.84(d)(2)The firm did not test finished batches of medical gas for identity, strength and impurities before releasing them for sale.
21 CFR 211.165(a)Pressure and vacuum gauges had not been calibrated since November 2020, and the oxygen analyzer was calibrated far less often than the firm's own procedure required before each fill.
21 CFR 211.68(a)Repeated container-closure defects such as neck leaks and valve problems were not investigated, and employees recorded assay results, duplicated calibration results, and entered Nitrogen, NF test results without the equipment to run the test.
21 CFR 211.192The quality control unit released medical gases without reviewing finished batch records or confirming that batches met all quality attributes.
21 CFR 211.22(a)
What FDA wants
FDA tells the firm to correct the violations and reply in writing within 15 working days with detailed remediation plans, including independent reviews of its material, laboratory, investigation and quality systems, a data integrity investigation, and a retrospective look at gases already on the U.S. market. FDA also recommends hiring a qualified CGMP consultant to audit the whole operation.
Who should pay attention
- hospitals, clinics and home-care providers buying medical oxygen from small fillers
- companies that accept supplier certificates of analysis instead of testing
- distributors and retailers of medical gases
This is a summary. Read the original letter on fda.gov.